Free shipping on all orders over $ 500

Secukinumab

Cat. No. M1622

All AbMole products are for research use only, cannot be used for human consumption.

Secukinumab Structure
Synonym:

AIN457; CAS# 1229022-83-6

Size Price Availability Quantity
100ug USD 150  USD150 In stock
5mg USD 620  USD620 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Secukinumab (AIN457) is a high-affinity monoclonal antibody against interleukin (IL-17A). Secukinumab (AIN457) is a first-in-class anti-IL-17 agent in the study of plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis.

Product Citations
Chemical Information
Molecular Weight 147941.89
Formula C6584H10134N1754O2042S44
CAS Number 875356-43-7
Storage -80°C for long term
References

[1] Kristian Reich, et al. N Engl J Med. Bimekizumab versus Secukinumab in Plaque Psoriasis

[2] Hannah A Blair. Drugs. Secukinumab: A Review in Psoriatic Arthritis

[3] Hannah A Blair. Drugs. Secukinumab: A Review in Ankylosing Spondylitis

[4] Lubrano E, et al. Ther Clin Risk Manag. Secukinumab for ankylosing spondylitis and psoriatic arthritis.

[5] Dominique Baeten, et al. N Engl J Med. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

[6] Richard G Langley, et al. N Engl J Med. Secukinumab in plaque psoriasis--results of two phase 3 trials

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Secukinumab, AIN457; CAS# 1229022-83-6 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.